High-temperature pronucleus Argonaute nuclease capable of simultaneously cutting DNA and RNA and application of high-temperature pronucleus Argonaute nuclease

By isolating and expressing the high-temperature prokaryotic Argonaute nuclease GgeAgo, combining 5'-phosphorylation guide DNA, the problem of DNA unrotating restriction and insufficient application of pAgos under high temperature conditions is solved, and the DNA and RNA at high temperature is achieved. Efficient cleavage, suitable for DNA molecular manipulation and nucleic acid detection.

CN119060984AInactive Publication Date: 2024-12-03HUBEI UNIV

Patent Information

Application Number
CN202411096702.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, the self-decoction of DNA under high temperature conditions limits the application of Argonaute nuclease, and the research and application of pAgos are relatively limited, and there is a lack of high-temperature prokaryotic Argonaute nuclease that can efficiently cleave DNA and RNA in vitro.

Method used

A high-temperature prokaryotic Argonaute nuclease GgeAgo was isolated from thermophilic bacteria, and the recombinant plasmid was constructed through PCR technology and expressed in E. coli. It combines 5'-phosphorylated guide DNA for efficient cleavage, adapts to high-temperature conditions, and is at NaCl concentration and divalent metal ions remain active.

Benefits of technology

GgeAgo maintains high activity in the range of 50~85°C, can efficiently cut single-stranded and double-stranded DNA, and is suitable for DNA molecular operations, with a wide range of application prospects in the fields of nucleic acid detection and gene editing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060984A_ABST
    Figure CN119060984A_ABST
Patent Text Reader

Abstract

The invention provides a high-temperature prokaryotic Argonaute nuclease capable of cutting DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) at the same time and application of the high-temperature prokaryotic Argonaute nuclease, and belongs to the technical field of synthetic biology and biology. The invention firstly discovers that the Argonaute nuclease sourced from thermophilic bacteria is specifically A1) or A2): A1) the amino acid sequence is shown as SEQ ID NO.1; the 5 '-phosphorylated gDNA and 5'-hydroxylated gDNA can be used for mediating the shearing of a single-stranded nucleic acid target at the same time, the high temperature resistance is 50-85 DEG C, and the 5 '-phosphorylated gDNA / 5'-hydroxylated gDNA fusion protein has high specificity and is beneficial to promoting the development of DNA and RNA operation tools in vivo and in vitro.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the fields of synthetic biology and biotechnology, and in particular to a high-temperature prokaryotic Argonaute nuclease capable of simultaneously cutting DNA and RNA and an application thereof. Background Art

[0002] Argonaute (Ago) was first discovered by Karen Bohmert in 1998 in a study describing a mutant of Arabidopsis thaliana. Because the leaves of the mutant curled like the tentacles of the flat argonaut octopus, it was named after the flat argonaut octopus. Argonauta argo ) named the gene and the corresponding protein. Later, as the research deepened, it was found that Ago (Argonaute) protein is a class of programmable nucleases widely present in eukaryotes and prokaryotes, and is highly conserved in evolution. According to its source, Ago can be divided into pAgos and eAgos, most of which have a high degree of structural homology. The catalytically active pAgos and eAgos have similar catalytic processes, including guide binding, target recognition and catalysis. It is generally believed that eAgos evolved from pAgos, but most of the characterized pAgos cannot cut the target RNA under the guidance of gRNA like eAgos, and the physiological function of pAgos in the body is not as clear as eAgos.

[0003] Compared with the Cas nuclease widely used in gene editing, Ago does not have the requirements of PAM (Protospacer adjacent motif) and PFS (Protospacer flanking site) when identifying targets, has a wider targeting range, and the guide nucleic acids used can be DNA and RNA, which are generally shorter in length. Compared with room temperature Ago, the application prospects of high temperature Ago are more extensive. This is because many room temperature Agos do not have the unwinding function and cannot open the DNA double helix, which limits the application of Ago. However, under high temperature conditions, DNA can open the double helix by itself, which allows the Ago protein to play the role of nuclease shearing, thus the nucleic acid detection technology is available.

[0004] Currently, only a few pAgos have been characterized, and in vitro application studies of pAgos mainly use PfAgo and TtAgo from thermophilic organisms. Therefore, in order to increase the understanding of pAgos and better promote the development of in vitro gene editing tools, the discovery of new high-temperature pAgos and the exploration of their in vitro nuclease properties are crucial. Summary of the invention

[0005] The purpose of the present invention is to provide a high temperature prokaryotic Argonaute nuclease capable of cutting both DNA and RNA and its application in view of the above-mentioned deficiencies in the prior art. The Argonaute nuclease has high temperature thermal stability and can cut DNA or RNA efficiently and specifically.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions: The first object of the present invention is to provide a high temperature prokaryotic Argonaute nuclease that can cut both DNA and RNA, which is derived from thermophilic bacteria. The Argonaute nuclease is specifically as follows A1) or A2): A1) The amino acid sequence is shown in SEQ ID NO.1; A2) A fusion protein obtained by connecting a tag to the N-terminus or / and C-terminus of A1).

[0007] In order to facilitate the purification of the protein in A1), the tags shown in the following table can be connected to the amino terminus or carboxyl terminus of the protein composed of the amino acid sequence shown in SEQ ID No. 1 in the sequence table: Poly-Arg (RRRRR), Poly-His (HHHHHH), FLAG (DYKDDDK).

[0008] The second object of the present invention is to provide a biological material related to the above-mentioned Argonaute nuclease, which is any one of the following B1) to B6): B1) encoding the Argonaute nuclease according to claim 1 B2) an expression cassette containing the nucleic acid molecule according to B1); B3) a recombinant vector containing the nucleic acid molecule described in B1); B4) a recombinant microorganism containing the nucleic acid molecule described in B1); B5) a recombinant microorganism containing the expression cassette described in B2); B6) A recombinant microorganism containing the recombinant vector described in B3).

[0009] The third object of the present invention is to provide the use of the above-mentioned biological material in the preparation of Argonaute nuclease.

[0010] The fourth object of the present invention is to provide a method for preparing Argonaute nuclease, comprising the step of expressing the coding gene of the above protein in biological cells to obtain a protein having Argonaute nuclease activity; the biological cells are microbial cells.

[0011] The fifth object of the present invention is to provide the use of the above-mentioned Argonaute nuclease or biological material in cleaving nucleic acid.

[0012] The sixth object of the present invention is to provide a nucleic acid cleavage system, comprising the above-mentioned Argonaute nuclease, guide DNA, target nucleic acid and reaction buffer.

[0013] Furthermore, the length of the guide DNA is 13-40 nt, and the 5' end of the guide DNA is phosphorylated.

[0014] Preferably, the length of the guide DNA is 15-30 nt, such as 18, 19 or 20 nt.

[0015] Furthermore, the specificity of the Argonaute nuclease lies in the complementarity between the guide DNA and the target nucleic acid at positions 10-15.

[0016] Furthermore, Mn 2+ or Mg 2+ , the Mn 2+ The concentration of Mg is 0.05~10 mM, 2+ The concentration is 0.5~10 mM.

[0017] Furthermore, the temperature of the nucleic acid cleavage system is 30-85°C.

[0018] Furthermore, the NaCl concentration in the reaction buffer is 25-250 mM.

[0019] Furthermore, the target nucleic acid is one of single-stranded DNA, double-stranded DNA or plasmid DNA.

[0020] The seventh objective of the present invention is to provide the use of the above-mentioned Argonaute nuclease or the above-mentioned nucleic acid cleavage system in the preparation of reagents or kits for DNA molecule manipulation.

[0021] The eighth objective of the present invention is to provide the use of the above-mentioned Argonaute nuclease or the above-mentioned nucleic acid cleavage system in the preparation of a reagent or a kit or a biosensor for detecting a target nucleic acid molecule.

[0022] Compared with the prior art, the present invention has the following beneficial effects: (1) The present invention provides a high-temperature prokaryotic Argonaute nuclease that can cleave both DNA and RNA, which is derived from thermophilic bacteria and can utilize 5'-phosphorylated gDNA to mediate efficient cleavage of single-stranded nucleic acid targets.

[0023] (2) The optimal reaction temperature range of the Argonaute nuclease provided by the present invention is 50-85°C; Mn 2+ Mg 2 +As an active ion, it maintains high activity; and it has a certain tolerance to NaCl concentration, with a tolerance range of 25-250 mM; it has no obvious preference for the first base at the 5' end of gDNA; in addition to cutting single-stranded nucleic acid targets, the enzyme can also cut double-stranded linear DNA and plasmid DNA, and can cut supercoiled DNA into linear DNA at the position where the GC content of the plasmid is 29%-65%, which makes it useful for DNA-related molecular operations, such as DNA molecular cloning. The enzyme has good DNA and RNA cutting activity and high specificity, and has broad application prospects in the field of nucleic acid detection. GgeAgo will be conducive to the development of DNA and RNA manipulation tools in vivo and in vitro. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 Results of phylogenetic analysis (A) and multiple sequence alignment (B) of GgeAgo; Figure 2 The results of SDS PAGE electrophoresis analysis of the purified GgeAgo protein; Figure 3 is the determination result of the cleavage activity of GgeAgo; Figure 4 is the effect of 5' phosphorylated gDNA (A) length on GgeAgo cleavage activity; Figure 5 The results are the effects of divalent metal ion types on the cleavage activity of GgeAgo; Figure 6 Mn 2+ (A) and Mg 2+ Results of the effect of concentration (B) on the cleavage activity of GgeAgo; Figure 7 The result diagram of the temperature range required for the GgeAgo reaction; Figure 8 This is the result of the NaCl concentration range that GgeAgo can tolerate; Fig. 9 It is the result of GgeAgo's preference for the first base at the 5' base end of gDNA; Fig.10 It is the result of GgeAgo cutting and distinguishing single-point mismatches at different sites between gDNA and Target; Fig.11 The results of GgeAgo cutting double-stranded linear DNA (A) and the results of shearing the 29%-65% GC content position of pUC19 plasmid. Among them, OC represents open circular plasmid (one strand of the plasmid is broken); LIN represents linearized plasmid (double strands of the plasmid are broken); SC represents supercoiled plasmid. DETAILED DESCRIPTION

[0025] In order to make the purpose, technical solution and advantages of the present invention clearer, embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements with the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.

[0026] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods, usually according to conventional conditions such as the conditions described in the "Molecular Cloning Experiment Guide (4th Edition)" (Chinese version) published by Science Press, or according to the conditions recommended by the manufacturer. They are experimental operations well known to those skilled in the art, and the present invention is not limited thereto.

[0027] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0028] The present invention uses thermophilic bacteria as the starting strain to dig out a thermostable Argonaute nuclease, referred to as GgeAgo. The present invention constructs a recombinant plasmid pET28a-GgeAgo by PCR technology, transforms the recombinant plasmid into Escherichia coli, realizes the heterologous expression of GgeAgo, and then purifies the protein GgeAgo produced by the recombinant strain by Ni NTA column.

[0029] The present invention provides a nucleic acid cleavage system, comprising: (a) Guide DNA (gDNA); (b) Nuclease Argonaute (Ago); (c) Target nucleic acid: single-stranded DNA (ssDNA), single-stranded RNA (ssRNA), double-stranded DNA (dsDNA), plasmid DNA.

[0030] Example 1 Heterologous expression and purification of Argonaute nucleases: The nucleotide sequence of GgeAgo was synthesized by Jinkairui Biotechnology Co., Ltd. and cloned into the pET28a expression vector together with the C-terminal 6×His tag to obtain the pET28a-GgeAgo plasmid, which was then transformed into Escherichia coli Rosetta (DE3). A single colony was picked and inoculated into LB liquid medium containing kanamycin and cultured in a shaking incubator at 37°C. When the bacterial OD 600When it reaches 0.6-0.8, move to an 18°C ​​shaker and induce with IPTG overnight. Collect the cells by centrifugation, wash the cells with buffer, resuspend the cells in Buffer A, add PMSF at a final concentration of 1 mM, and break the cells under high pressure. Collect the supernatant by centrifugation. After filtering the supernatant, perform Ni-NTA purification. Perform gradient elution with 20 mM-500 mM imidazole, and take samples for SDS-PAGE detection. Collect the eluted fractions containing high-purity target proteins. Perform a second purification using molecular sieves (Superdex 200 16 / 600 column, GE Healthcare). Collect the purified protein, identify the purity and analyze it using SDS-PAGE, collect the eluted fractions containing high-purity target proteins, and freeze them for later use.

[0031] The results of SDS-PAGE analysis of the purified high-purity GgeAgo protein are as follows: Figure 2 As shown, the protein band of GgeAgo conforms to the expected size of 82.3 kDa calculated by http: / / www.expasy.org / . The evolutionary tree of GgeAgo and some characterized Argonaute proteins (Ago proteins) is shown in Figure 1 A shows the catalytic DEDX quadruplex of GgeAgo and its sequence alignment with 17 characterized Ago proteins. Figure 1 As shown in B.

[0032] Example 2 Determination of Argonaute nuclease cleavage activity: Design fluorescently modified 45 nt single-stranded DNA and RNA target nucleic acids and four complementary 18 nt guide DNA and RNA, synthesized by a biological company, the specific sequences are as follows Figure 3 (above). Prepare the reaction buffer (containing 10 mM HEPES-NaOH pH 7.5, 100 mM NaCl, 5% glycerol), add MnCl2 with a final concentration of 5 mM, 800 nM GgeAgo, 400 nM synthetic gDNA or gRNA to the reaction buffer, incubate at 50°C for 10 min to form Ago-gDNA complex, then add 200 nM fluorescent single-stranded DNA or RNA target nucleic acid complementary to the guide sequence, react at 50°C for 30 min, add loading buffer (containing 95% formamide, 18 mM EDTA, 0.025% bromophenol blue, 0.025% SDS) at a ratio of 1:1 after the reaction, mix and heat at 95°C for 5 min to terminate the reaction. Detected by 20% denaturing PAGE electrophoresis, stained with SYBR Gold (Invitrogen), and visualized with GelDocTM XR+ (Bio-Rad), the cleavage results of GgeAgo on single-stranded nucleic acid targets are shown as follows. Figure 3 (below).

[0033] The results showed that no product band (34 nt) was observed in the control assay of guide-target reaction (DNA / RNA) without GgeAgo, indicating that the formation of the product band was the result of the nuclease activity of GgeAgo. GgeAgo can cleave DNA and RNA targets using both 5' phosphorylated guide DNA and 5' hydroxylated guide DNA, and the cleavage activity guided by the 5' phosphorylated guide is higher.

[0034] Example 3 Determination of Argonaute nuclease cleavage activity: 1. Investigate the effects of guide DNA of different lengths on GgeAgo's recognition and cleavage of single-stranded nucleic acid targets.

[0035] 5' phosphorylated DNA with a length of 13-40 nt was selected as the guide DNA, which was incubated with GgeAgo to form a complex, and the effect of different lengths of guide DNA on GgeAgo's recognition and cleavage of single-stranded nucleic acid targets was measured. The results are shown in Figure 4 shown.

[0036] The results showed that the length of the guide DNA has a certain effect on the activity of GgeAgo in recognizing and cutting single-stranded nucleic acid targets. GgeAgo can effectively cut single-stranded nucleic acid targets using guide DNA with a length of 15-30 nt, among which the cutting effect is best when the guide DNA length ranges from 18-30 nt.

[0037] 2. Investigate the effect of divalent metal cations on the cleavage activity of Argonaute nuclease.

[0038] To explore the effect of divalent metal cations on the cleavage activity of GgeAgo, GgeAgo and guide DNA were mixed in a reaction buffer containing different divalent metal cations at a final concentration of 5 mM, and incubated at 50 °C for 10 min to form Ago-gDNA complexes, and then nucleic acid targets were added for cleavage activity detection. The divalent metal cations were selected from Mn 2+ ,Mg 2+ , Ca 2+ , Cu 2+ , Fe 2+ ,Co 2+ , Zn 2+ and Ni 2+ , the effect of different metal cations on the cleavage activity was determined, and the results were as follows Figure 5 shown.

[0039] The results showed that GgeAgo can utilize Mn 2+ Mg2+ 、Co 2+ Mn can also be used as a metal ion to mediate 5' phosphorylation guide DNA-guided ssDNA target cleavage. 2+ Mg 2+ As a metal ion-mediated 5' phosphorylation guide DNA-guided single-stranded RNA target cleavage. Among them, GgeAgo prefers Mn 2+ .

[0040] Further exploration of Mn 2+ and Mg 2+ The effect of concentration on the cleavage activity of GgeAgo was studied by selecting 0.01 mM to 10.00 mM Mn 2+ or 0.5 mM to 10.00 mM Mg 2+ Add to the buffer and measure the cleavage activity of GgeAgo on single-stranded nucleic acid targets. The results are as follows Figure 6 shown.

[0041] The results show that the concentration of divalent metal cations has a certain effect on the cleavage activity of GgeAgo. 2+ The final concentration is ≥ 0.05 mM or Mg 2+ When the final concentration is ≥2.5 mM, obvious cleavage products can be produced.

[0042] 3. Investigate the effect of temperature on the cleavage activity of Argonaute nuclease.

[0043] After GgeAgo was incubated with the guide DNA to form a complex, the target sequence was added at different temperatures (30 ℃, 37 ℃, 40 ℃, 45 ℃, 50 ℃, 55 ℃, 60 ℃, 65 ℃, 70 ℃, 75 ℃, 80 ℃, 85 ℃, 90 ℃) and reacted for 15 min. The cleavage activity was measured. The results are shown in Figure 2. Figure 7 shown.

[0044] The results showed that when the guide was 5' phosphorylated DNA, GgeAgo could cut single-stranded nucleic acid targets within the temperature range of 30-85 °C, and its activity increased with increasing temperature. It is worth noting that since the active temperature of RNase inhibitors is around 65 °C, reaction temperatures above 65 °C will cause significant degradation of RNA targets, so the highest temperature of the RNA target cutting experiment was only 75 °C. In summary, GgeAgo can exert endonuclease activity under a wide range of temperature conditions.

[0045] 4. Investigate the effect of different reaction buffer concentrations on the cleavage activity of Argonaute nuclease.

[0046] Adjust the reaction buffer composition to prepare reaction buffers with a final concentration of 10 mM HEPES-NaOH pH 7.5 and different concentrations of NaCl (25 mM, 50 mM, 100 mM, 150 mM, 200 mM, 250 mM), add the nucleic acid cleavage system and react for 15 min, then measure the cleavage activity. The results are as follows: Figure 8 shown. The results showed that GgeAgo could exert cleavage activity in the final NaCl concentration range of 25-50 mM, among which, the cleavage activity of GgeAgo was the best when the final NaCl concentration was 100 mM.

[0047] 5. Investigate the ability of GgeAgo to distinguish between single-point base non-complementary cleavage at different sites between the guide DNA and the target nucleic acid.

[0048] 18 nt gDNAs with the first base at the 5' end of gDNA being A, T, G, or C were designed and added to the corresponding nucleic acid cleavage system. After reacting for 5-60 min, the preference of GgeAgo for the first base at the 5' end of gDNA under the mediation of 5' phosphorylated guide DNA was measured.

[0049] The results are as follows Fig. 9 The results show that GgeAgo has no obvious preference for the first base at the 5' end of gDNA and can be located at any of the four bases. A series of gDNAs with single-point mismatches at different sites (MP 1-18) with the single-stranded nucleic acid target were designed. The other reaction conditions remained unchanged, and the single-stranded nucleic acid cleavage system was added to the reaction to measure the differential cleavage effect of GgeAgo.

[0050] The results are as follows Fig.10 The results showed that when the mismatch occurred at positions 7 and 10-15 of gDNA, the activity of GgeAgo in cutting DNA targets was significantly reduced, among which the mismatch site with the lowest cutting activity occurred at position 11 of gDNA; and when the mismatch occurred at positions 11-15 of gDNA, the activity of GgeAgo in cutting RNA targets was significantly reduced, among which the mismatch site with the lowest cutting activity occurred at position 12 of gDNA.

[0051] Example 4 Argonaute nuclease cleavage of DNA molecules: Forward and reverse gDNAs with targeted GC contents of 29%, 39%, 45%, 53%, 64%, and 65% (within 200 bp upstream and downstream of the cleavage site) were designed and synthesized for cleaving double-stranded DNA and the two chains of plasmid pUC19. The sequences are shown in Table 1.

[0052] Table 1.

[0053] After GgeAgo was incubated with the forward and reverse gDNAs corresponding to the target cleavage sites with different GC contents to form Ago-single-stranded gDNA complexes, the forward and reverse gDNAs were mixed with the complexes formed by GgeAgo, and then 200 ng of double-stranded DNA target or pUC19 plasmid was added to react at 70 °C for 30 min. After the reaction, 100 ng of the reaction sample was added to 5× loading buffer and detected by electrophoresis in 1% agarose gel.

[0054] The results are as follows Fig.11 The results showed that GgeAgo can effectively cut double-stranded DNA with a GC content of 29-64% near the shearing site; when the GC content near the shearing site is 29% and 39%, GgeAgo can use a pair of gDNA to shear all supercoiled plasmids into linear plasmids; when the GC content near the shearing site is 45%, 53%, 64%, and 65%, GgeAgo can use a pair of gDNA to convert supercoiled plasmids into open circular plasmids and linear plasmids. For matters not mentioned above, the prior art applies.

[0055] Although some specific embodiments of the present invention have been described in detail through examples, those skilled in the art should understand that the above examples are for illustration only and are not intended to limit the scope of the present invention. Those skilled in the art to which the present invention belongs may make various modifications or supplements to the specific embodiments described or replace them in a similar manner, but they will not deviate from the direction of the present invention or exceed the scope defined by the attached claims. Those skilled in the art should understand that any modifications, equivalent substitutions, improvements, etc. made to the above embodiments based on the technical essence of the present invention should be included in the protection scope of the present invention.

Claims

1. A high temperature prokaryotic Argonaute nuclease capable of cleaving both DNA and RNA, characterized in that: Derived from thermophilic bacteria, the Argonaute nuclease is specifically as follows A1) or A2): A1) The amino acid sequence is shown in SEQ ID NO.1; A2) A fusion protein obtained by connecting a tag to the N-terminus or / and C-terminus of A1).

2. The biological material related to the Argonaute nuclease according to claim 1, which is any one of the following B1) to B6): B1) a nucleic acid molecule encoding the Argonaute nuclease according to claim 1; B2) an expression cassette containing the nucleic acid molecule described in B1); B3) a recombinant vector containing the nucleic acid molecule described in B1); B4) a recombinant microorganism containing the nucleic acid molecule described in B1); B5) a recombinant microorganism containing the expression cassette described in B2); B6) A recombinant microorganism containing the recombinant vector described in B3).

3. Use of the biomaterial according to claim 2 in the preparation of Argonaute nuclease.

4. A method for preparing Argonaute nuclease, characterized in that: The method comprises the steps of expressing the gene encoding the Argonaute nuclease according to claim 1 in a biological cell to obtain a protein having Argonaute nuclease activity; the biological cell is a microbial cell.

5. Use of the Argonaute nuclease according to claim 1 or the biomaterial according to claim 2 in nucleic acid shearing.

6. A nucleic acid cleavage system, characterized in that: The nucleic acid cleavage system can be used in vivo and in vitro, and comprises: (a) guide DNA; (b) the Argonaute nuclease according to claim 1; (c) an optional target nucleic acid; and (d) a reaction buffer.

7. The nucleic acid cleavage system according to claim 6, characterized in that The length of the guide DNA is 13-40 nt, and the 5' end of the guide DNA is phosphorylated and can be any of 4 bases.

8. The specificity of the Argonaute nuclease according to claim 6, characterized in that: The guide DNA is complementary to the target nucleic acid at positions 10-15.

9. The nucleic acid cleavage system according to claim 6, characterized in that Including Mn 2+ or Mg 2+ , the Mn 2+ The concentration of Mg is 0.05~10 mM, 2+ The concentration is 0.5~10 mM.

10. The nucleic acid cleavage system according to claim 6, wherein The temperature of the nucleic acid cleavage system is 30-85° C., and the NaCl concentration in the reaction buffer of the nucleic acid cleavage system is 25-250 mM.

11. The nucleic acid cleavage system according to claim 6, characterized in that The target nucleic acid is one of single-stranded RNA, single-stranded DNA, double-stranded DNA or plasmid DNA.

12. Use of the Argonaute nuclease according to claim 1 or the nucleic acid cleavage system according to any one of claims 6 to 11 in the preparation of reagents or kits for DNA molecule manipulation.

13. Use of the Argonaute nuclease according to claim 1 or the nucleic acid cleavage system according to any one of claims 6 to 11 in preparing a reagent or a kit or a biosensor for detecting a target nucleic acid molecule.

Citation Information

Patent Citations

  • Novel mesothermal prokaryotic Argonaute protein PbAgo characterization and application

    CN113046355A

  • Application of medium-high temperature Argonaute protein in specific cleavage of target nucleic acid

    CN115975985A

Cited By

  • Method for rapidly and accurately cutting RNA (Ribonucleic Acid) based on MfAgo nuclease

    CN120829896A